Company: LGNZZ
Filing Date: 2025-05-08
Form Type: 8-K
Source: 0000886163-25-000033
Chunk: 1

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-05-08
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                       
         99.1      Press release dated May 8, 2025.  
 ─────────────────────────────────────────────────────

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                         LIGAND PHARMACEUTICALS INCORPORATED       
  Date: May 8, 2025      By: /s/ Andrew Reardon